Table 2.
Saline group (n = 10) | ADR group (n = 16) | ADR-Cil group (n = 16) | ADR-Aml group (n = 16) | |
---|---|---|---|---|
Ejection fraction (%) | 72.0 ± 1.4 | 49.7 ± 2.6††† | 57.5 ± 2.2* | 52.6 ± 2.6 |
Fractional shortening (%) | 34.8 ± 1.2 | 20.9 ± 1.5††† | 25.1 ± 1.3* | 22.4 ± 1.4 |
Left ventricular mass (g) | 1.20 ± 0.1 | 1.14 ± 0.02 | 1.06 ± 0.02* | 1.13 ± 0.03 |
Left ventricular mass/body weight (g/g) | 0.31 ± 0.0 | 0.39 ± 0.01††† | 0.36 ± 2.2* | 0.38 ± 0.01 |
P < 0.001 for the comparison with the saline group; *P < 0.05 for the comparison with the ADR group.
Spontaneously-hypertensive rats were treated with ADR, followed by administration of vehicle (ADR group), 20 mg/kg per day cilnidipine (ADR-Cil group), or 3 mg/kg per day amlodipine (ADR-Aml group) for 4 weeks. Saline group received saline rather than ADR, followed by vehicle for 4 weeks.
ADR, adriamycin; Aml, amlodipine; BP, blood pressure; BW, body weight; Cil, cilnidipine.